Wilmington, Delaware, United States, April 11, 2023 (GLOBE NEWSWIRE) -- According to market research by TMR, the global in vivo toxicology industry is expected to witness significant growth during the forecast period from 2023 to 2033. The global business was valued at USD 5.2 Bn in 2022 and is expected to reach USD 9.5 Bn by 2033 with CAGR of 5.6%.
In vivo toxicology is significant in identifying the relative toxicity and providing detailed analysis of the effect of particular diseases on human health through animal tests. The inferences based on the observation of animals and the effects of toxicity on various organs can assist medical professionals in identifying potential health threats and prescribing safe medicines accordingly. In vivo toxicology plays a crucial role in drug development, as it involves the development of medicine and vaccines using clinical inferences based on animal testing and research
For Insights on Global, Regional, and Country-Level Parameters with Growth Opportunities By 2033 - Download A Sample Report!
In Vivo Toxicology Market Scope:
| Report Coverage | Details | |
| Market Revenue | USD 5.2 Bn in 2022 | |
| Estimated Value | USD 9.5 Bn by 2033 | |
| Growth Rate | 5.6% | |
| Forecast Period | 2023–2033 | |
| No. of Pages | 250 Pages | |
| Segmentation | By Product, Test Type, Testing Facility, Toxicity End Point and End User | |
| Regions Covered | North America, Europe, Asia Pacific, Middle East & Africa, South America | |
| Companies Covered | Charles River Laboratories, THE JACKSON LABORATORY, Envigo, Taconic Biosciences, Inc., genOway, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, BioSpace, and Bio-Rad Laboratories | |
The biotechnological and pharmaceutical industries are focusing on the development of effective drugs with the integration of advanced technology. During the onset of the global COVID-19 pandemic, the in vivo toxicology market witnessed lucrative growth owing to the rise in demand for drug development for COVID-19 patients. Thus, in vivo toxicology served as a prominent testing method during the pandemic and enhanced the process of vaccine and drug development, which in turn propelled business growth.
In Vivo Toxicology Market: Growth Drivers
- Rise in incidence of various diseases, including cancer and diabetes, has created growth opportunities in the global market. Biotechnological and pharmaceutical industries are focusing on developing novel and efficient technologies, such as gene therapy, through toxicology testing. These aspects are driving global industry growth.
- In vivo studies in toxicology involve the development of effective drugs and vaccines through animal testing. The observation and inferences of research outcomes assist professionals to identify and cure diseases effectively. It also helps increase the efficacy of drugs and vaccines.
- Emerging trends in the healthcare sector to provide effective treatment procedures through relentless research & development have created attractive growth prospects for the global market. Furthermore, rise in investment in developing drugs, vaccines, and therapeutics with precision is likely to augment the global industry.
Request for Customization to Meet Your Exact Research Needs: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=85513
Key Findings of In Vivo Toxicology Market
- In terms of product, the consumables segment is projected to expand at a CAGR of 4.4% during the forecast period. Increase in usage of kits and reagents in R&D activities has increased demand for consumables, which in turn is likely to drive the segment.
- Based on end-user, the academic & research institutes segment is expected to witness significant growth as a result of exhaustive research in the healthcare sector to produce efficient lines of treatment. This involves toxicity testing, drug development, and other R&D. Increase in demand for toxicology testing has influenced the growth of the segment.
In Vivo Toxicology Market: Regional Dynamics
The market in North America was valued at US$ 2.1 Bn in 2022. The region is projected to witness robust growth during the forecast period. Well-developed healthcare infrastructure, technological advancements, and government funding for research & development are expected to accelerate market expansion in the region. Furthermore, increase in prevalence of lung cancer in countries such as the U.S. has created a pressing need for the evaluation of toxicity involved in targeted therapies, chemotherapy drugs, and other treatment procedures.
The market in Europe is likely to grow at a rapid pace during the forecast period. Increase in incidence of hepatitis B and increase in contract research activities, especially in countries such as the U.K., is projected to spur the in vivo toxicology market in the region.
Asia Pacific is also anticipated to offer lucrative opportunities, as a result of increased clinical trials to evaluate the efficacy of drugs and the development of novel drugs and therapies in countries such as India and China.
In Vivo Toxicology Market: Competitive Landscape
Research & development is crucial for the growth of the global in vivo toxicology market. Players are investing in R&D activities to gain competitive advantage. Major players engage in strategic alliances through mergers, acquisitions, joint ventures, and partnerships. These activities strengthen the influence of the players.
Key players operating in the global market are:
- Taconic Biosciences, Inc.
- Agilent Technologies
- Bruker Corporation
- BioSpace
- Danaher Corporation
- THE JACKSON LABORATORY
- BioRad Laboratories
Buy this Premium Research Report | Immediate Delivery Available at https://www.transparencymarketresearch.com/checkout.php?rep_id=85513<ype=S
In Vivo Toxicology Market: Segmentation
By Product
- Instruments
- Consumables
- Reagents & Kits
- Animal Models
By Test Type
- Acute
- Sub-acute
- Sub-chronic
- Chronic Test Type
By Testing Facility
- Outsourced Testing Facility
- In-house Testing Facility
By Toxicity End Point
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Development and Reproductive Toxicity
- Other Toxicity End Point
By End-user
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Others
By Regions
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
